Lei Zhang

机构：Tianjin University of Commerce, University of Science and Technology of China, Tianjin University of Technology, Anhui University, Hefei University of Technology, Bengbu Medical College, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Inner Mongolia Autonomous Region Meteorological Bureau, Army Sustainment University, First Hospital of Shijiazhuang, Tiandi Science & Technology (China), Air Force General Hospital PLA, Institute of Hematology & Blood Diseases Hospital, Dian Diagnostics (China), First Affiliated Hospital of Bengbu Medical College, Wuhan YZY Biopharma (China), China Coal Technology and Engineering Group Corp (China), Ningxia Machinery Research Institute (China), United States Air Force Academy, Jinzhou Medical University, Shaanxi Normal University · ORCID：0000-0001-7769-7377

发表论文 1216 篇 · 总被引 23759 次 · h-index 66

代表论文

• Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials (2025 · Nature Medicine · 被引 9)
• Ianalumab plus Eltrombopag in Immune Thrombocytopenia (2025 · New England Journal of Medicine · 被引 4)
• Influence of altitudinal zones on soil nutrient dynamics and fertility constraints in agricultural terrains of Yunnan, China (2025 · Scientific Reports · 被引 3)
• Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment (2025 · Blood · 被引 3)
• Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism (2025 · Journal of Clinical Investigation · 被引 1)
• Targeting DESI2 as a Novel Therapeutic Strategy for JAK2‐Mutant Leukemias (2025 · Advanced Science · 被引 1)